4J26 | pdb_00004j26

Estrogen Receptor in complex with proline-flanked LXXLL peptides

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
C [auth B]	SCOP2B Superfamily	Nuclear receptor ligand-binding domain	8038722	3001442	SCOP2B (2022-06-29)
A	SCOP2B Superfamily	Nuclear receptor ligand-binding domain	8038722	3001442	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
C [auth B]		e4j26B1	A: central helical domain in RNA-polymerase beta-prime subunit	X: central helical domain in RNA-polymerase beta-prime subunit	H: central helical domain in RNA-polymerase beta-prime subunit	T: RNA_pol_Rpb1_5	F:	ECOD (20:10:01)
A		e4j26A2	A: Subtilisin-like	X: Subtilisin-like	H: Subtilisin-like	T: Chorismate_bind	F:	ECOD (20:10:01)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
C [auth B]	1.10.565.10	Mainly Alpha	Orthogonal Bundle	Retinoid X Receptor	Retinoid X Receptor	CATH (4.3.0)
A	1.10.565.10	Mainly Alpha	Orthogonal Bundle	Retinoid X Receptor	Retinoid X Receptor	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, C [auth B]	PF00104	Ligand-binding domain of nuclear hormone receptor (Hormone_recep)	Ligand-binding domain of nuclear hormone receptor	This all helical domain is involved in binding the hormone in these receptors.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
B [auth I], D [auth J]	12-mer Peptide	-	-	-
A, C [auth B]	Estrogen receptor beta	DNA binding sequence-specific DNA binding binding double-stranded DNA binding nucleic acid binding RNA polymerase II transcription regulatory region sequence-specific DNA binding cis-regulatory region sequence-specific DNA binding sequence-specific double-stranded DNA binding transcription cis-regulatory region binding transcription regulatory region nucleic acid binding RNA polymerase II cis-regulatory region sequence-specific DNA binding nuclear receptor activity nuclear steroid receptor activity DNA-binding transcription factor activity, RNA polymerase II-specific DNA binding sequence-specific DNA binding binding double-stranded DNA binding nucleic acid binding RNA polymerase II transcription regulatory region sequence-specific DNA binding cis-regulatory region sequence-specific DNA binding sequence-specific double-stranded DNA binding transcription cis-regulatory region binding transcription regulatory region nucleic acid binding RNA polymerase II cis-regulatory region sequence-specific DNA binding nuclear receptor activity nuclear steroid receptor activity DNA-binding transcription factor activity, RNA polymerase II-specific molecular transducer activity transcription regulator activity DNA-binding transcription factor activity signaling receptor activity nuclear estrogen receptor activity ligand-modulated transcription factor activity molecular function inhibitor activity molecular function regulator activity signaling receptor inhibitor activity receptor antagonist activity signaling receptor regulator activity estrogen response element binding steroid binding lipid binding cation binding transition metal ion binding zinc ion binding ion binding metal ion binding small molecule binding protein binding enzyme binding	regulation of biological process signaling biological regulation cell-cell signaling cellular process cell communication regulation of growth regulation of cellular component organization regulation of cellular process negative regulation of biological process growth negative regulation of cell growth regulation of cell growth cell growth regulation of biological process signaling biological regulation cell-cell signaling cellular process cell communication regulation of growth regulation of cellular component organization regulation of cellular process negative regulation of biological process growth negative regulation of cell growth regulation of cell growth cell growth cellular component organization negative regulation of growth negative regulation of cellular process cellular component organization or biogenesis cellular response to stimulus response to stimulus signal transduction RNA metabolic process regulation of primary metabolic process nucleobase-containing compound metabolic process RNA biosynthetic process nucleic acid biosynthetic process DNA-templated transcription regulation of RNA metabolic process regulation of nucleobase-containing compound metabolic process regulation of RNA biosynthetic process regulation of biosynthetic process primary metabolic process regulation of macromolecule metabolic process nucleobase-containing compound biosynthetic process gene expression macromolecule biosynthetic process nucleic acid metabolic process regulation of gene expression biosynthetic process metabolic process regulation of macromolecule biosynthetic process regulation of DNA-templated transcription macromolecule metabolic process regulation of metabolic process intracellular receptor signaling pathway response to lipid hormone-mediated signaling pathway intracellular signal transduction cellular response to endogenous stimulus response to hormone response to steroid hormone nuclear receptor-mediated steroid hormone signaling pathway cellular response to steroid hormone stimulus steroid hormone receptor signaling pathway cellular response to hormone stimulus response to endogenous stimulus estrogen receptor signaling pathway cellular response to chemical stimulus response to chemical cellular response to lipid nuclear receptor-mediated signaling pathway positive regulation of DNA-templated transcription positive regulation of biological process positive regulation of macromolecule biosynthetic process positive regulation of metabolic process positive regulation of biosynthetic process positive regulation of macromolecule metabolic process positive regulation of cellular process positive regulation of RNA metabolic process positive regulation of RNA biosynthetic process response to oxygen-containing compound cellular response to oxygen-containing compound response to estradiol cellular response to estradiol stimulus transcription by RNA polymerase II regulation of transcription by RNA polymerase II negative regulation of RNA biosynthetic process negative regulation of nucleobase-containing compound metabolic process negative regulation of macromolecule metabolic process negative regulation of DNA-templated transcription negative regulation of transcription by RNA polymerase II negative regulation of metabolic process negative regulation of biosynthetic process negative regulation of macromolecule biosynthetic process negative regulation of RNA metabolic process positive regulation of transcription by RNA polymerase II	membrane-bounded organelle intracellular organelle cellular anatomical structure intracellular anatomical structure mitochondrion organelle cytoplasm intracellular membrane-bounded organelle nucleus membrane-enclosed lumen intracellular organelle lumen nucleoplasm organelle lumen nuclear lumen membrane-bounded organelle intracellular organelle cellular anatomical structure intracellular anatomical structure mitochondrion organelle cytoplasm intracellular membrane-bounded organelle nucleus membrane-enclosed lumen intracellular organelle lumen nucleoplasm organelle lumen nuclear lumen membraneless organelle intracellular membraneless organelle chromatin chromosome

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, C [auth B]	IPR001628	Zinc finger, nuclear hormone receptor-type	Domain
A, C [auth B]	IPR028355	Estrogen receptor beta/gamma	Family
A, C [auth B]	IPR024178	Estrogen receptor/oestrogen-related receptor	Family
A, C [auth B]	IPR050200	Nuclear hormone receptor family NR3 subfamily	Family
A, C [auth B]	IPR001723	Nuclear hormone receptor	Family
A, C [auth B]	IPR013088	Zinc finger, NHR/GATA-type	Homologous Superfamily
A, C [auth B]	IPR000536	Nuclear hormone receptor, ligand-binding domain	Domain
A, C [auth B]	IPR035500	Nuclear hormone receptor-like domain superfamily	Homologous Superfamily
A, C [auth B]	IPR021064	Estrogen receptor beta-like, N-terminal	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, C [auth B]	Pharos: Q92731	transitional cell carcinoma endometriosis medulloblastoma atrial fibrillation childhood cerebral astrocytoma juvenile pilocytic astrocytoma cocaine dependence coronary artery disease adenocarcinoma melanotic medulloblastoma adult medulloblastoma endometrial carcinoma prostate cancer astrocytic tumor sarcomatoid carcinoma transitional cell carcinoma endometriosis medulloblastoma atrial fibrillation childhood cerebral astrocytoma juvenile pilocytic astrocytoma cocaine dependence coronary artery disease adenocarcinoma melanotic medulloblastoma adult medulloblastoma endometrial carcinoma prostate cancer astrocytic tumor sarcomatoid carcinoma breast carcinoma fibrillary astrocytoma granular cell carcinoma tubular adenocarcinoma childhood medulloblastoma Lithiasis urinary bladder cancer familial medullary thyroid carcinoma protoplasmic astrocytoma female infertility carcinoma gemistocytic astrocytoma subependymal giant cell astrocytoma cocaine abuse colorectal cancer medullomyoblastoma with myogenic differentiation anaplastic astrocytoma pilocytic astrocytoma prostate intraepithelial neoplasia psoriasis breast cancer major depressive disorder colorectal carcinoma cribriform carcinoma of breast postmenopausal osteoporosis mammary neoplasms, animal desmoplastic/nodular medulloblastoma amelogenesis imperfecta type 1G endogenous depression ovarian cancer prostate carcinoma astrocytoma (excluding glioblastoma) bipolar disorder schizophrenia cerebral astrocytoma undifferentiated carcinoma lung cancer urinary bladder neoplasm cribriform carcinoma diffuse astrocytoma endometrial cancer

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.